Study guide

23.3 Integration into Family, School, Work, Camp, and Social Environment

Certified Pediatric Hematology Oncology Nurse CPHON®

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy

2 Care Continuum

2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship

3 Leukemias and Lymphomas

3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas

4 CNS, Neuroblastoma, and Renal Tumors

4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors

5 Sarcomas and Other Solid Tumors

5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors

6 Hematologic Disorders

6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure

7 Pathophysiology, Genetics, and Diagnostics

7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis

8 Clinical Trials and Professional Performance

8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education

9 Chemotherapy and Biotherapy

9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy

10 Immunotherapy, Cellular Therapy, and Radiation

10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam

11 HSCT, Surgery, Transfusion, and Coagulation Therapy

11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy

12 Neurologic, Respiratory, and Cardiovascular Effects

12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects

13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects

13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects

14 Endocrine, Hematologic, Immunologic, and Sensory Effects

14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects

15 Pain, Sleep, Fatigue, and Mental Health

15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects

16 Supportive Care

16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care

17 Infectious and Gastrointestinal Emergencies

17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction

18 Metabolic Emergencies

18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome

19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome

19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)

20 Sickle Cell and Hemostasis Emergencies

20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed

21 Cardiopulmonary Emergencies

21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias

22 Neurologic and Infusion Emergencies

22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation

23 Family, Caregivers, and Social Integration

23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment

24 Development, Grief, Culture, and Community Resources

24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources

23.3 Integration into Family, School, Work, Camp, and Social Environment

Key Takeaways Explain This Topic AI

Hospital or homebound school continues education during long admissions; community return uses a 504 plan for accommodations and an IEP when specialized instruction is needed—not a rule that every oncology patient must have an IEP.

Re-entry after alopecia, amputation or limb salvage, and cognitive late effects is planned with the child; disclosure to classmates is the family's choice, not a hallway announcement.

Sports clearance must consider central lines, splenomegaly or splenectomy, thrombocytopenia, and cardiomyopathy or anthracycline exposure rather than a blanket ban or blanket clearance.

Neutropenic school policies are individualized; isolation that cuts off all developmentally needed peers is not automatically safer.

Oncology camps follow camp infection rules; AYA work and college need internist or PCP letters and disability-services paperwork that do not automatically inherit a K-12 IEP.

Last updated: August 2026

TCO VI.A.3 is integration into family, school, work, camp, and the social environment . An 11-year-old finishing delayed intensification has alopecia, a port, and a wish to play soccer. The absolute neutrophil count (ANC) is low this week. A 16-year-old after femoral resection wants gym class. A 5-year-old after cranial radiation is "fine" at home and lost at school. Isolation that "protects counts" can starve development. The exam tests whether you can put the child back into a life, not only into a clinic chair.

Hospital school and the 504 / IEP distinction

During a long admission, hospital school (or homebound instruction coordinated with the home district) keeps the child a student. It is not optional enrichment. Ask what the district needs: a physician letter, hours, and a named school contact. Do not wait until discharge to discover the child has missed eight weeks with no instruction. A 9-year-old on a six-week neuroblastoma admission who never sees a hospital teacher is already behind, even if counts recover.

Return to community school usually needs a written plan:

A Section 504 plan provides accommodations so a student with a disability can access school: reduced day, extra time, elevator, rest breaks, unlimited bathroom or water, a clinic pass for fever, PE modifications, homebound during nadirs, and a hat or scarf policy that the child chose. Many children on chemotherapy need 504 support even when they do not need special education.

An individualized education program (IEP) under special-education law is for a student who needs specialized instruction and related services, not only accommodations. Cognitive late effects after cranial radiation, brain-tumor treatment, or intensive central-nervous-system (CNS) therapy, hearing loss after cisplatin, or significant motor change after amputation may warrant IEP evaluation. Do not invent a rule that every oncology patient must have an IEP, and do not invent a rule that 504 is "lesser so skip it."

Plans should travel with the student across grades. College does not automatically inherit a K-12 IEP; AYA students need disability-services paperwork under disability law, usually with letters from oncology or the internist/primary care provider (PCP).

Re-entry after visible and invisible change

Alopecia is not cosmetic to a child. Plan re-entry before the first day back: a hat or wig if the child wants one, a teacher who will not joke, and a bathroom pass. Some children want to walk in bald and own it; some do not. Follow the child.

Amputation or limb salvage needs bathroom access, elevator, backpack weight limits, and PE that is not public failure. A classmate staring is a nursing and school-nurse problem, not the child's job to absorb alone. A 14-year-old after distal femoral replacement who is sent to dress for full contact PE on day one of return has not been integrated; they have been exposed.

Cognitive late effects —slowed processing, working-memory trouble, fatigue after CNS treatment—are easy to miss because the child "looks well." Flag them early for 504 or IEP evaluation rather than waiting for failing grades to prove the injury. A 7-year-old after medulloblastoma who needs extra time is not lazy.

Disclosure, sports, and individualized neutropenia policy

Disclosure to classmates belongs to the child and family. Offer choices: child-life or school-nurse visit with a practiced script; a letter the family approves; or no group announcement. Do not have a principal announce diagnosis over the intercom. HIPAA still applies: the school nurse needs the fever plan, line precautions, and who to call—not the genomic report.

Sports clearance is individualized and must consider:

Issue Why it changes gym and sports Typical nursing / team action

Central line or accessed port Trauma, pull, water exposure Protect the site; limit contact while accessed; swimming rules are institutional

Splenomegaly Rupture risk from contact Hold contact until the spleen is not a rupture risk

Splenectomy / asplenia Infection risk; fever is an emergency Counsel; do not issue a lifetime ban without the team; vaccines and fever plan travel to camp and locker rooms

Thrombocytopenia Bleeding, intracranial risk No contact, no diving, head protection as directed until counts recover

Cardiomyopathy or anthracycline exposure Exertional risk Cardiology or oncology clearance; modified PE, not a teacher guessing

There is no single ONCC ANC number that bans or permits school for every child. Neutropenic school policies are individualized : a child with a brief expected nadir, a reliable family, and a school nurse may attend with a fever plan; a child with profound neutropenia, mucositis, and no school nurse may need homebound that week. Isolation that cuts off all peers—no video, no sibling, no one friend outdoors—is not automatically safer and is developmentally costly. A toddler still needs play; an AYA still needs friends.

Camp, letters, AYA work and college, peers

Oncology camps exist because children need cancer-informed peers. They still have infection rules : screening for fever, varicella or measles exposure, central-line care, and camp-specific ANC or device policies. Do not tell a family to ignore camp rules because the child "needs friends." Do not tell a family that camp is medically forbidden for every child with a port. Send the records the camp requires. A varicella exposure at camp is a same-day call to oncology, not a secret so the child can stay for the talent show.

Letters from the oncology team, internist, or PCP should state what the receiving adult actually needs: fever number, line type, activity limits, medications at school, and who to call. A 17-year-old starting college or a job needs a fever plan for a dorm or workplace, a disability-services contact, and a PCP or internist who has the treatment summary—not a vague "may return as tolerated."

AYA work and college are developmental needs, not luxuries. Reduced hours, remote class during nadirs, and a roommate who knows the fever rule are accommodations. Isolation from every peer to "protect the counts" can be as harmful as a missed antibiotic. The CPHON balance is infection risk plus developmentally needed peers .

The CPHON product is a student with a 504 or IEP that matches real deficits, a disclosure plan the child chose, sports that were cleared for the line and the heart and the platelets, a camp packet that tells the truth, and an AYA who has a letter—not a child who survived intensive therapy only to disappear from childhood.

Loading diagram... Re-entry path from hospital school to camp, work, and college

School and social re-entry layers the CPHON nurse sequences